Coherently, high level of RGS2 was also found in gastric cancer cells, and was closely connected with TIDE, and CD8+ T-cell infiltration in other cancer types (Yang et al., 2022), indicating that RGS2 could studied further as a new target for immunotherapy on gastric cancer. The gene discussed is RGS2; the disease is gastric cancer.